Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Astria Therapeutics (ATXS) Notes Payables: 2017-2018

Historic Notes Payables for Astria Therapeutics (ATXS) over the last 1 years, with Jun 2018 value amounting to $831,000.

  • Astria Therapeutics' Notes Payables fell 74.65% to $831,000 in Q2 2018 from the same period last year, while for Jun 2018 it was $831,000, marking a year-over-year decrease of 74.65%. This contributed to the annual value of $2.5 million for FY2017, which is N/A change from last year.
  • Astria Therapeutics' Notes Payables amounted to $831,000 in Q2 2018, which was down 49.85% from $1.7 million recorded in Q1 2018.
  • Astria Therapeutics' 5-year Notes Payables high stood at $3.3 million for Q3 2017, and its period low was $831,000 during Q2 2018.
  • Its 2-year average for Notes Payables is $2.5 million, with a median of $2.9 million in 2017.
  • Data for Astria Therapeutics' Notes Payables shows a maximum YoY crashed of 74.65% (in 2018) over the last 5 years.
  • Over the past 2 years, Astria Therapeutics' Notes Payables (Quarterly) stood at $2.5 million in 2017, then tumbled by 74.65% to $831,000 in 2018.
  • Its last three reported values are $831,000 in Q2 2018, $1.7 million for Q1 2018, and $2.5 million during Q4 2017.